TABLE I.

Demographics and Iron-Scoring of Hepatis-Negative Patients with SCD and TM

	SCD	TM	P-value
Age	14.3 ± 6.5	14.9 ± 8.8	0.73
Gender	15 M, 14 F	17 M, 24 F	0.47
Chelator	DFO, 23	DFO, 36	–
	None, 5	None, 4
		DFP, 1
Hemoglobin	9.3 ± 0.7	9.6 ± 0.8	0.15
Liver iron by biopsy	16.2 ± 8.6	18.1 ± 15.9	0.56
Total score	29.3 ± 7.5	26.5 ± 8.9	0.20
Hepatocyte score	17.1 ± 5.7	15.5 ± 6.8	0.32
Sinusoidal score	9.1 ± 1.6	7.9 ± 2.5	0.036
Portal score	3.1 ± 2.0	3.1 ± 2.0	0.92
Fibrosis	0.6 ± 0.6	1.2 ± 0.8	0.003*
Inflammation	0.7 ± 0.7	0.9 ± 0.7	0.17

^*Significant at P < 0.05 after Bonferroni correction.

DFO, deferoxamine; DFP, deferiprone.